Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Remko A. de Jong"'
Autor:
Hugo Vrenken, Paolo Bosco, Giovanni B. Frisoni, Baptiste Grenier, Frederik Barkhof, Adriaan Versteeg, Alberto Redolfi, Ronald A. van Schijndel, Peter J. Visser, Bob W. van Dijk, Jérôme Revillard, Remko A. de Jong, E. Mulder, Keith S. Cover, Soheil Damangir, David Manset, Kelvin K. Leung
Publikováno v:
Psychiatry Research: Neuroimaging, 252, 26-35. Elsevier Ireland Ltd
Psychiatry Research: Neuroimaging, Vol. 252 (2016) pp. 26-35
Cover, K S, van Schijndel, R A, Versteeg, A, Leung, K K, Mulder, E R, Jong, R A, Visser, P J, Redolfi, A, Revillard, J, Grenier, B, Manset, D, Damangir, S, Bosco, P, Vrenken, H, van Dijk, B W, Frisoni, G B & Barkhof, F 2016, ' Reproducibility of hippocampal atrophy rates measured with manual, FreeSurfer, AdaBoost, FSL/FIRST and the MAPS-HBSI methods in Alzheimer's disease ', Psychiatry Research: Neuroimaging, vol. 252, pp. 26-35 . https://doi.org/10.1016/j.pscychresns.2016.04.006
Psychiatry Research: Neuroimaging, Vol. 252 (2016) pp. 26-35
Cover, K S, van Schijndel, R A, Versteeg, A, Leung, K K, Mulder, E R, Jong, R A, Visser, P J, Redolfi, A, Revillard, J, Grenier, B, Manset, D, Damangir, S, Bosco, P, Vrenken, H, van Dijk, B W, Frisoni, G B & Barkhof, F 2016, ' Reproducibility of hippocampal atrophy rates measured with manual, FreeSurfer, AdaBoost, FSL/FIRST and the MAPS-HBSI methods in Alzheimer's disease ', Psychiatry Research: Neuroimaging, vol. 252, pp. 26-35 . https://doi.org/10.1016/j.pscychresns.2016.04.006
The purpose of this study is to assess the reproducibility of hippocampal atrophy rate measurements of commonly used fully-automated algorithms in Alzheimer disease (AD). The reproducibility of hippocampal atrophy rate for FSL/FIRST, AdaBoost, FreeSu
Autor:
Nick C. Fox, Frederik Barkhof, Remko A. de Jong, Ronald A. van Schijndel, Bob W. van Dijk, David Manset, Giovanni B. Frisoni, Hugo Vrenken, Jérôme Revillard, Alberto Redolfi, Baptiste Grenier, E. Mulder, Keith S. Cover, Kelvin K. Leung, Adriaan Versteeg, Pieter Jelle Visser
Publikováno v:
Alzheimer's & Dementia. 10
Background: The reproducibility of algorithms for longitudinal hippocampal percentage volume change (PVC) measurement has direct repercussions on clinical trial design in diseases such as Alzheimer's (AD). The ADNI1 study provides an excellent data s